Breaking News

Close

Gilead Sciences Inc (GILDCL)

	Symbol	Exchange	Currency
	GILD	NASDAQ	USD	Real-time
	GILD	Mexico	MXN	Delayed
	GGILD	Milan	EUR	Real-time
	GILD	Xetra	EUR	Delayed
	GILD	TradeGate	EUR	Delayed
	GILD	Frankfurt	EUR	Delayed
	GILD	Buenos Aires	ARS	Delayed
	GILD	Vienna	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

Gilead historical data, for real-time data please try another search

0.00 0.00 0.00%

30/11 - Closed. Currency in CLP ( Disclaimer )

Volume: 0
Bid/Ask: 0.00 / 0.00
Day's Range: 0.00 - 0.00

Type: Equity

Market: Chile

ISIN: US3755581036

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
- Analyst Price Target
Forum

GILDCL Balance Sheet

Assess the latest Gilead balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Annual Quarterly

InvestingPro

Advanced Balance Sheet

Period Ending:

2023

31/03

2022

31/12

2022

30/09

2022

30/06

Total Current Assets

13456

14443

13554

13175

Cash and Short Term Investments	6518	7144	6238	6140
Cash	-	-	-	-
Cash & Equivalents	4936	5412	4699	4739
Short Term Investments	1582	1732	1539	1401
Total Receivables, Net	4162	4777	4354	4118
Accounts Receivables - Trade, Net	4162	4777	4354	4118
Total Inventory	1576	1507	1463	1494
Prepaid Expenses	1169	955	1274	1296
Other Current Assets, Total	31	60	225	127

Total Assets

61876

63171

62557

62870

Property/Plant/Equipment, Total - Net	5479	5980	5349	5299
Property/Plant/Equipment, Total - Gross	-	8166	-	-
Accumulated Depreciation, Total	-	-2186	-	-
Goodwill, Net	8314	8314	8314	8314
Intangibles, Net	28348	28894	29440	29885
Long Term Investments	2642	2611	2596	2836
Note Receivable - Long Term	-	-	-	-
Other Long Term Assets, Total	3637	2929	3304	3361
Other Assets, Total	-973	-1478	-1127	-1096

Total Current Liabilities

10528

11237

10423

9220

Accounts Payable	627	905	614	565
Payable/Accrued	-	-	-	-
Accrued Expenses	4184	6534	6245	6349
Notes Payable/Short Term Debt	-	-	-	-
Current Port. of LT Debt/Capital Leases	2283	2384	2270	1021
Other Current liabilities, Total	3434	1414	1294	1285

Total Liabilities

40937

41962

41500

42655

Total Long Term Debt	22956	22957	22953	25195
Long Term Debt	22956	22957	22953	25195
Capital Lease Obligations	-	-	-	-
Deferred Income Tax	2401	2673	3036	3364
Minority Interest	-58	-31	-24	-21
Other Liabilities, Total	5110	5126	5112	4897

Total Equity

20939

21209

21057

20215

Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	1	1	1	1
Additional Paid-In Capital	5793	5550	5226	5031
Retained Earnings (Accumulated Deficit)	15223	15687	15756	15117
Treasury Stock - Common	-	-	-	-
ESOP Debt Guarantee	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-
Other Equity, Total	-78	-29	74	66

Total Liabilities & Shareholders' Equity

61876

63171

62557

62870

Total Common Shares Outstanding

1248

1247

1254

1254

Total Preferred Shares Outstanding

-

-

-

-

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good job GILD. bullish move forward

0 0

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Up Again

1 0

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Time to load up before the big rise coming next week

3 3

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Classic pump n’ dump. What a shambles

5 1

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Will reach above 95

10 5

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

when? hahah

0 0

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good time to accumulate.

4 1

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

High chance to be trading above 90, good long stock

9 4

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	FTSE 100	7,595.51	-4.23	-0.06%
	DAX	15,964.55	-25.41	-0.16%
	Euro Stoxx 50	4,294.75	-2.93	-0.07%
	S&P 500	4,293.93	+26.41	+0.62%
	Nikkei 225	32,265.17	+623.90	+1.97%
	Dow Jones	33,833.61	+168.59	+0.50%
	FTSE 100 Futures	7,601.2	-5.3	-0.07%

	Brent Oil	75.81	-0.15	-0.20%
	Crude Oil WTI	71.16	-0.13	-0.18%
	Gold	1,975.60	-3.00	-0.15%
	Silver	24.483	+0.135	+0.55%
	Copper	3.8130	+0.0180	+0.47%
	London Cocoa	2,415.00	+0.00	+0.00%
	London Wheat	172.55	-2.30	-1.32%

	U.K. 10Y	4.2860	+0.0590	+1.40%
	U.K. 5Y	4.2625	+0.0585	+1.39%
	U.K. 2Y	4.5500	+0.0540	+1.20%
	Germany 10Y	2.4265	+0.0045	+0.19%
	U.S. 10Y	3.755	+0.042	+1.14%
	U.S. 5Y	3.901	+0.045	+1.15%
	U.S. 2Y	4.572	+0.053	+1.17%

	Lloyds Banking	45.58	+0.25	+0.55%
	Vodafone Group PLC	75.00	+0.85	+1.15%
	Barclays	157.74	+0.12	+0.08%
	BT Group	148.20	+0.60	+0.41%
	HSBC	611.40	+0.40	+0.07%
	BHP Group Ltd	2,402.38	+23.00	+0.97%
	Exxon Mobil	108.19	-0.34	-0.31%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILDCL	0.00	0.00	0.00%

	Name	Last	Chg. %	Vol.
	NatWest Group	263.50	+0.96%	7.54M
	Network International Holdings	384.00	+5.84%	2.36M
	HSBC	611.40	+0.07%	1.22M
	Shell	2,301.7	-0.33%	1.02M
	Rio Tinto PLC	5,194.0	+1.31%	150.87K
	Flutter Entertainment	15,395.0	-0.29%	71.50K
	AstraZeneca	11,838.0	+0.75%	70.00K

	Name	Last	Chg. %	Vol.
	Amigo	0.85	+161.54%	50.52M
	Itsarm	0.42	+88.89%	17.60M
	SAF Holland	11.50	+71.77%	0.14K
	Spar Nord Bank	106.80	+55.23%	0.13K
	Campari	12.74	+25.88%	40.01K
	Betsson	106.70	+25.83%	1.22K
	Saipem	1.31	+20.45%	112.36K

	Name	Last	Chg. %	Vol.
	H Lundbeck B	36.32	-79.09%	0.63K
	AMS	6.97	-66.16%	6.74K
	Atlas Copco B	138.45	-63.36%	6.42K
	Tomra Systems	166.95	-51.99%	1.47K
	MFE MEDIAFOREUROPE NV B	0.649	-46.32%	8.63K
	ALK-Abello B	86.75	-41.95%	5.50K
	MTG B	62.90	-39.58%	0.33K